PharmaSentinel and Pay10 Forge Innovative Partnership for Enhanced Digital Health Solutions
PharmaSentinel Limited, a leading player in AI-driven digital health solutions, has announced a pivotal licensing agreement with Pay10, a well-recognized digital payment platform. This strategic partnership aims to not only enhance PharmaSentinel's core product, Medsii.com but also assist Pay10 in strengthening its offerings within a specific vertical market segment.
Medsii.com is an advanced B2B platform that leverages artificial intelligence to provide a verified, holistic overview of scientific, clinical, regulatory, and competitive information. This innovative tool positions PharmaSentinel to effectively penetrate the thriving global health analytics market, valued at GBP 25 billion annually, with an impressive growth rate of 20% per year.
Fabrizio Ballantini, CEO of PharmaSentinel, highlighted that this collaboration marks a significant milestone for the company, underlining the growing demand for comprehensive information solutions. He stated, "This agreement confirms our technology platform amidst increasing needs within the pharmaceutical and biotech sectors. It also emphasizes our commitment to fostering innovation and informed decision-making."
Despite its main focus on Life Sciences, the underlying technology utilized in Medsii.com is adaptable to other regulated sectors, such as legal and financial services. Through this collaboration, Pay10 seeks to bolster its information services, offering enhanced regulatory insights and support to users worldwide. By working together, both companies aim to drive innovation and improve data accessibility for stakeholders globally.
PharmaSentinel, based in the UK, utilizes AI to provide timely, personalized, and regulatory-compliant medication information. Its robust and scalable platform ensures GDPR compliance and assists pharmaceutical entities in acquiring critical information faster, ultimately saving costs and enabling them to focus on more valuable activities.
Medsii.com stands out by providing reliable global health and medication news, informing users about various medical conditions and potential drug interactions. It is designed to present personalized health and medication information accessible to users worldwide.
On the other hand, Pay10 specializes in simplifying and securing financial transactions for individuals and businesses through its comprehensive digital payment platform. The company offers an array of services, including a digital wallet, payment gateway, and merchant app. For enterprises, Pay10 provides tools that help broaden customer reach, streamline transactions and access in-depth analytics. Its platform is certified according to industry standards to ensure secure and efficient payment operations.
While the terms of the partnership remain confidential, this collaboration signifies a promising venture aimed at enhancing the digital health landscape and improving services within the sector. For more information, interested parties may contact Fabrizio Ballantini, CEO of PharmaSentinel Limited.
For media inquiries:
Email: [email protected]
Photo and Logo Links:
This agreement represents an intersection of health technology and digital payments, signifying the growing trend towards integrated solutions in healthcare and finance that aim to enhance user experiences across various platforms.
Medsii.com is an advanced B2B platform that leverages artificial intelligence to provide a verified, holistic overview of scientific, clinical, regulatory, and competitive information. This innovative tool positions PharmaSentinel to effectively penetrate the thriving global health analytics market, valued at GBP 25 billion annually, with an impressive growth rate of 20% per year.
Fabrizio Ballantini, CEO of PharmaSentinel, highlighted that this collaboration marks a significant milestone for the company, underlining the growing demand for comprehensive information solutions. He stated, "This agreement confirms our technology platform amidst increasing needs within the pharmaceutical and biotech sectors. It also emphasizes our commitment to fostering innovation and informed decision-making."
Despite its main focus on Life Sciences, the underlying technology utilized in Medsii.com is adaptable to other regulated sectors, such as legal and financial services. Through this collaboration, Pay10 seeks to bolster its information services, offering enhanced regulatory insights and support to users worldwide. By working together, both companies aim to drive innovation and improve data accessibility for stakeholders globally.
PharmaSentinel, based in the UK, utilizes AI to provide timely, personalized, and regulatory-compliant medication information. Its robust and scalable platform ensures GDPR compliance and assists pharmaceutical entities in acquiring critical information faster, ultimately saving costs and enabling them to focus on more valuable activities.
Medsii.com stands out by providing reliable global health and medication news, informing users about various medical conditions and potential drug interactions. It is designed to present personalized health and medication information accessible to users worldwide.
On the other hand, Pay10 specializes in simplifying and securing financial transactions for individuals and businesses through its comprehensive digital payment platform. The company offers an array of services, including a digital wallet, payment gateway, and merchant app. For enterprises, Pay10 provides tools that help broaden customer reach, streamline transactions and access in-depth analytics. Its platform is certified according to industry standards to ensure secure and efficient payment operations.
While the terms of the partnership remain confidential, this collaboration signifies a promising venture aimed at enhancing the digital health landscape and improving services within the sector. For more information, interested parties may contact Fabrizio Ballantini, CEO of PharmaSentinel Limited.
For media inquiries:
Email: [email protected]
Photo and Logo Links:
This agreement represents an intersection of health technology and digital payments, signifying the growing trend towards integrated solutions in healthcare and finance that aim to enhance user experiences across various platforms.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.